Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Accured Expenses: 2013-2025

Historic Change in Accured Expenses for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to -$13.7 million.

  • Phibro Animal Health's Change in Accured Expenses fell 288.42% to -$13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 155.68%. This contributed to the annual value of $47.2 million for FY2025, which is 286.90% up from last year.
  • According to the latest figures from Q3 2025, Phibro Animal Health's Change in Accured Expenses is -$13.7 million, which was down 152.41% from $26.1 million recorded in Q2 2025.
  • In the past 5 years, Phibro Animal Health's Change in Accured Expenses ranged from a high of $26.1 million in Q2 2025 and a low of -$13.7 million during Q3 2025.
  • In the last 3 years, Phibro Animal Health's Change in Accured Expenses had a median value of -$199,000 in 2025 and averaged $4.0 million.
  • As far as peak fluctuations go, Phibro Animal Health's Change in Accured Expenses soared by 1,357.99% in 2024, and later crashed by 288.42% in 2025.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Change in Accured Expenses stood at $5.2 million in 2021, then rose by 15.57% to $6.0 million in 2022, then surged by 36.38% to $8.2 million in 2023, then soared by 202.80% to $24.8 million in 2024, then plummeted by 288.42% to -$13.7 million in 2025.
  • Its Change in Accured Expenses was -$13.7 million in Q3 2025, compared to $26.1 million in Q2 2025 and -$199,000 in Q1 2025.